- Primary Care Is in Trouble. So Doctors Band Together To Boost Their Market Power.
- Cosmetic Surgery Investigation Prompts Warnings for Patients, and a Push for Tighter Safety Standards
- Driving the news at HIMSS26: Verily, Samsung ink collaboration; Meditech's latest AI solutions
- Minnesota to give $5M in restitution to patients of shuttered dental office
- Dental group owners, employee convicted of fraud, conspiracy
- The ‘farm mentality’ and what it means for ASCs
- What 5 physician practice closures say about the industry in 2026
- The Loss No One Measures: The True Cost of Pharmacy Vacancies
- Maryland hygiene school opens 1st VR lab
- Colorado hospitals, advocates launch youth mental health coalition
- Pennsylvania hospital CFO on life after bankruptcy: ‘You’ve got to hold the line’
- Pennsylvania hospital CFO on life after bankruptcy: ‘You’ve got to hold the line’
- Medicare allegedly paid $15M+ for ED services tied to non-ED sites: Report
- Medicare allegedly paid $15M+ for ED services tied to non-ED sites: Report
- ECMC Corp. CEO to leave for New York hospital association role
- CMS’ ambulatory specialty payment model: 10 things to know
- Climate warming could increase anxiety, depression: Study
- HSHS, Lifepoint name CEO for planned Wisconsin hospital
- Tennessee lawmakers weigh expanding optometrists’ scope of practice
- Washington hospital settles open meetings lawsuit
- ‘No rational explanation’: Hospitals warn Colorado budget cuts will shrink physician pipeline
- HCA Florida hospital CEO retires
- TriHealth CEO to retire
- Sutter Health boosts operating margin to 2.6% in 2025
- Sutter Health boosts operating margin to 2.6% in 2025
- $13.4B premium hike due to Medicare Advantage overpayments: Report
- Remarks at the Institute of International Bankers 2026 Annual Washington Conference
- Choice Healthcare Services to upgrade 2 dental practices
- The ‘perfect storm’ threatening anesthesia
- Tennessee’s CON repeal delay endangers rural health funding
- Private equity invested $1 trillion in healthcare in 10 years: Report
- Why this specialty is facing an increased risk in False Claims allegations
- Fostering Regulatory Harmony Between the SEC and CFTC
- The anesthesia reimbursement math that no longer works for ASCs
- Only 4 states satisfy over 50% of mental health workforce needs: Report
- Here's where hospital markets are the most concentrated
- Federal report scrutinizes vertical integration in dentistry: 6 notes
- A look at how CVS is leaning on 'agentic twins' in developing consumer tech
- Washington poised to ban noncompete agreements
- Elevance to expand 10% out-of-network penalty policy into California
- Bancos, primera línea de batalla contra los fraudes financieros a adultos mayores
- 1st dental MRI earns FDA clearance
- U of Minnesota requests $100M in funding to expand dental school
- Inside Grand Mental Health’s tech-enabled crisis response model
- Sandoz to set up standalone biosimilars unit as it eyes upcoming 'golden decade' of patent losses
- 14 DSO deals reshaping dentistry
- Indiana syringe services face ID requirement, restrictions
- EDs see jump in pediatric dental visits: 5 notes
- NYU Stern report calls for private equity reforms to safeguard quality of care
- AbbVie's Robert Michael earns hefty pay bump to $32.5M in 2nd year as CEO
- The Aspen Group’s 2025 dental growth in 10 numbers
- DME company owner sentenced in $60M fraud scheme
- Remarks at the International Bar Association’s 24th Annual International Conference on Private Investment Funds
- 2 revenue cycle leaders on strategies that reduced denials
- Raw Oysters and Clams Recalled After Norovirus-Like Illness Outbreak in Washington
- Mammograms May Also Reveal Hidden Heart Disease Risk, Study Finds
- Chile Becomes First Country in the Americas To Eliminate Leprosy
- Going Abroad? CDC Warns Travelers About Polio Risk in Several Countries
- Listen to the Latest ‘KFF Health News Minute’
- 20 payer relations executives to know
- 9 health systems naming revenue cycle vice presidents
- Más niños llegan a salas de emergencias con dolor de muelas. Los recortes de Trump y la lucha anti flúor de RFK Jr. no ayudan
- Centene's stock falls as CEO London outlines ongoing ACA headwinds
- AI-fueled misdiagnoses, rural care barriers are 2026's top patient safety threats: ECRI
- Patients want price transparency, e-commerce experience from pharma DTP platforms: survey
- Carrum Health teams up with Virta Health on a comprehensive weight loss solution
- Leerink questions whether BioNTech can thrive without their 'founders' insight' as stock drops
- Novo Nordisk's US headquarters under fire in latest FDA warning letter
- Filana leaves Cassava roots behind amid branch into epilepsy
- Nearly Half of U.S. Kids Lack Adequate Sleep, Survey Shows
- Trump Caused Immediate Decrease in Acetaminophen Rx's For Pregnant Women, Study Finds
- Students Spend A Third Of Their School Day On Their Smartphone, Study Says
- Daily Multivitamins Slow Aging, Clinical Trial Finds
- Stress of Pregnancy Complications Might Impact Future Heart Health, Study Says
- Approved IV Drug, Gazvya, Reduces Lupus Symptoms, Clinical Trial Finds
- CSL telegraphs 300 new hires as it breaks ground on $1.5B plasma-based medicine plant near Chicago
- More Kids Are in ERs for Tooth Pain. Trump Cuts and RFK Jr.’s Anti-Fluoride Fight Aren’t Helping.
- Banks Are Becoming Bulwarks Against Scams for Vulnerable Seniors
- FDA approves leucovorin for ultrarare cerebral folate deficiency subset without clinical trial
- BioNTech's CEO, CMO prep departure to set up next-gen mRNA company
- 12 new behavioral health sites to know
- HIMSS26: Samsung, b.well partner to 'kill the clipboard,' aligning with a key CMS goal
- HIMSS26: Epic expands AI road map, previews Factory to build and orchestrate AI agents
- A $21M farewell: Emma Walmsley lands nearly 50% pay hike in final year as GSK chief
- Fitch upgrades UCHealth’s rating to ‘AA+’
- Autism committee delays first meeting
- Maryland behavioral health providers push for 3% reimbursement rate increase
- Remarks at the 45th Annual Small Business Forum
- Founders, Funders, and Forty-Five Forums: Remarks at the 45th Annual Small Business Forum
- Remarks at the 45th Annual Small Business Forum
- Leapfrog ordered to remove safety grade for 5 Tenet hospitals
- FDA unveils 4th revision of draft guidance for looser biosimilar testing requirements
- 4 behavioral healthcare M&A deals in 2026
- 'Fibermaxxing' Trend Encourages People To Eat More Fiber
- Lilly rewards CEO David Ricks with $36.7M pay package for 2025, fueled by GLP-1 success
- Crossroads Healing Centers earns Joint Commission accreditation
- That Stressful Person in Your Life Might Be Aging You Faster, Study Finds
- Newsom se enfrenta a Trump y RFK Jr. por la salud pública
- Infant Bath Seats Sold on Amazon Recalled Due To Tipping Hazard
- FDA Vaccine Chief Dr. Vinay Prasad Exiting Role
- Spruce hooks a commercial chief to prep for rare disease launch
- Hims & Hers makes deal with Novo Nordisk as it shifts obesity strategy
- Fierce Healthcare highlights Fierce 15 of 2026 honorees at NYSE
- Universal Health Services to acquire Talkspace in $835M deal to build out virtual behavioral health
- Florida no amplió Medicaid, pero igual algunos legisladores quieren imponer requisitos de trabajo
- Novo and Hims make nice, striking deal to sell Ozempic, Wegovy on Hims' telehealth platform
- Sotyktu, take 2: BMS' first-in-class pill gains FDA nod to treat psoriatic arthritis
- 'SNL' pokes fun at mysteries of Amgen's Otezla for plaque psoriasis
- Novo's troubled Indiana plant claims another victim as FDA rejects Incyte's lung cancer application
- Weighted Vests Help Keep Bones Strong — But Only If Seniors Stay Active
- Small Drop In Measles Vaccinations Tied to Big Jump In Cases
- UV Air Filters Cut Airborne Asthma Triggers, Study Finds
- Many Seniors Gain Physical, Mental Fitness As They Age, Study Finds
- Common Drug Class, Anticholinergics, Shows Links to Heart Risk — Are You Taking One?
- Illicit Drugs Raise Stroke Risk, Even for Younger Adults
- Ipsen backs away from cancer med Tazverik after safety signals emerge in lymphoma trial
- Florida Hasn’t Expanded Medicaid. Lawmakers Want To Add Work Requirements Anyway.
- Omada Health swings to a profit in Q4, offers new GLP-1 cash-pay option for employers
- Most Americans Say They Don’t Trust Driverless Cars — Here’s Why
- Can The Critters in Your Mouth Cause or Cure Disease?
- FDA's Vinay Prasad to depart agency at the end of April
- KFF: A look at Part D enrollment trends for 2026
- Healthcare Dealmakers—Hims & Hers goes international with Eucalyptus purchase, Humana's CenterWell buys MaxHealth and more
- Lonza hands off capsule business to investment firm Lone Star in $3B deal
- Some Patients Keep Weight off With Fewer GLP-1 Injections, Study Finds
- Democrats press 11 pharmas for 'any evidence' their Trump pricing deals deliver savings for Medicaid
- Democrats press 11 pharmas for 'any evidence' their Trump pricing deals deliver savings for Medicaid
- RFK Jr. Urges Medical Schools To Add More Nutrition Training
- Sixth Measles Case Confirmed in New Mexico Jail
- Community Health System selling 4 Arkansas hospitals to Freeman Health System for $112M
- Philips unveils Rembra CT for acute and high-demand imaging environments
- Philips unveils Rembra CT for acute and high-demand imaging environments
- 45,000 Halo Magic Sleepsuits For Babies Recalled Over Choking Risk
- Op-Ed—American healthcare has a pricing problem
- GLP-1 Weight-Loss Drugs Prove Effective Across Diverse Patient Groups
- Angry Teens May Age Faster, Study Finds
- Chronic Pain Can Make Noise Unbearable By Rewiring The Brain, Study Says
- Telemedicine Not Closing the Mental Health Gap in Rural Areas
- Racial Disparities Persist In Lung Cancer Treatment, Study Finds
- Peanut Allergy Risk Higher If Older Sibs Eat Peanuts, Study Finds
- Salesforce partners with HealthEx, Verily and Viz.ai to build out healthcare AI agents
- Rising Tree Pollen Counts Signal Start of Allergy Season
- Experts call for more data, collaboration to address gun violence at annual Northwell forum
- Finding the Right Supportive Footwear for Pain Relief is Key, Say Podiatrists
- FTC seeing 'progress' in discussions with Optum, Caremark in insulin case
- Fewer Mothers Died During Pregnancy or After Birth in 2024
- Trader Joe's Pulls Frozen Meals Tied to 37 Million-Pound Nationwide Recall
- Optum teams with Microsoft to expand AI-powered claims platform
- RadNet Acquires Gleamer to Support Position as a Radiology Clinical AI Solutions Leader
- RadNet Acquires Gleamer to Support Position as a Radiology Clinical AI Solutions Leader
Walgreens Boots Alliance Inc. has been supporting their stores with pharmacy profits as they lose a lot of money on their other retail lines. This bodes ill for controlling prescription drug costs in America, and will further challenge inner city residents seeking to fill their prescriptions:
Walgreens plans to close 1,200 stores as it looks for a turnaround
Walgreens’ stock has been hammered this year as consumer shopping patterns have changed, but the company’s latest earnings are getting better reception
By Emily Bary - October 15, 2024Walgreens Boots Alliance Inc. plans to shutter about 1,200 stores over the next three years in a bid to improve earnings.
The retail and pharmacy chain has struggled in recent years as shopping preferences have changed and consumers have moved to buy more products online. Walgreens previously embarked on a cost-cutting plan largely targeting the retail pharmacy business.
Walgreens announced the three-year plan for store closures alongside its earnings Tuesday morning, with the company noting that about 500 of the closures are expected in fiscal year 2025, which just began.
The company expects the move will prove immediately accretive to adjusted earnings per share and free cash flow.
After a deeply disappointing report three months back that brought a guidance cut and ushered in a 22% one-day stock decline, Walgreens’ latest results are getting a better reception on Wall Street. Shares are up 5% in premarket action Tuesday as Walgreens cleared the consensus view on both revenue and earnings.
The results “reflected our disciplined execution on cost management, working capital initiatives and capex reduction,” Chief Executive Tim Wentworth said in a release.
Walgreens’ revenue rose 6% to $37.5 billion, while analysts were looking for $35.8 billion.
The company’s U.S. retail pharmacy business saw a 6.5% sales gain in the quarter as well as an 8.3% rise in comparable sales. Pharmacy sales were up 9.6%, or 11.7% on a comparable-sales basis, reflecting “higher brand inflation and mix impact,” according to Walgreens’ earnings release.
Retail sales fell 3.5%, while comparable retail sales were down 1.7%, “reflecting a challenging retail environment and continued channel shift,” Walgreens said.
The company posted a fiscal fourth-quarter net loss of $3.0 billion, or $3.48 a share, compared with $180 million, or 21 cents a share, in the year-earlier period. The sizable loss included multiple non-cash charges.
On an adjusted basis, Walgreens earned 39 cents a share, while analysts tracked by FactSet were modeling 36 cents a share.
For fiscal 2025, Walgreens models $1.40 to $1.80 in adjusted earnings per share, while the FactSet consensus was for $1.72. The company expects its U.S. healthcare business and international business to grow, while the U.S. retail pharmacy business is anticipated to decline. The company is also looking for $147 billion to $151 billion in fiscal 2025, sales, while analysts were modeling $147.6 billion.
“Fiscal 2025 will be an important rebasing year as we advance our strategy to drive value creation,” Wentworth said. “This turnaround will take time, but we are confident it will yield significant financial and consumer benefits over the long term.”
Walgreens shares are down 66% so far this year.
NPR reporter Alina Selyukh has posted a backgrounder on the troubles at CVS and Walgreen's:
https://www.npr.org/2024/10/16/nx-s1-5154129/cvs-and-walgreens-closing-stores-why
CVS and Walgreens are ailing. Here’s why
By Alina Selyukh - October 16, 2024Not too long after Tim Wentworth became CEO of Walgreens, he revealed a stunning figure: Roughly a quarter of the pharmacy chain’s stores do not make money.
On Tuesday, he said 1,200 of those stores will close over three years. That’s two weeks after rival CVS announced layoffs of 2,900 corporate staff. Both chains are on a multibillion-dollar cost-saving spree — closing hundreds of locations, cutting thousands of jobs and, really, reconsidering their role in Americans’ lives.
The slow simmer of mistakes and misfortunes has come to a boil for the biggest U.S. drugstore chains. They’ve accumulated too many stores at a time of changing shopper habits. They’re saddled with numerous government fines and a particularly ailing relationship with health insurers.
The problem of stores
CVS and Walgreens have some notable differences. Walgreens, which also owns the British drugstore Boots, is more singularly focused on its pharmacy business. CVS has expanded further into health care through mergers with insurer Aetna and Caremark, a pharmacy benefit manager that helps insurers negotiate prescription drug coverage and costs. Yet the two companies have made similar missteps.
The simplest part of the problem is scale. CVS and Walgreens grew massive nationwide footprints of more than 9,000 and 8,000 stores, respectively. They gobbled up mom-and-pop shops and signed long-term leases for prime locations on street corners.
Now, shoppers regularly complain about chronically understaffed stores, with products locked up to prevent theft. The shelves of snacks, makeup, greeting cards and cleaning products were meant to boost profits. But sales have sagged for years — a result of a losing battle with Amazon, Walmart, Costco, grocery and dollar stores.
CVS and Walgreens “probably do have too many stores because they overexpanded, but the bigger problem is that the stores that they have are not very good,” said Neil Saunders, retail analyst at the firm GlobalData.
The chains have failed to add new incentives for shoppers, beyond photo booths and returns drop-off centers, says Anshuman Jaiswal, a longtime consultant to retailers and pharmacies. And neither chain has built a meaningful online presence designed to give customers what they need.
“If you go to CVS.com or Walgreens.com, if you are placing an order for cough syrup, why don't I sell chicken broth as a product recommendation immediately?” Jaiswal says. “It's about reimagining the business model.”
The problem of prescriptions
Given the retail struggles, pharmacies could perhaps simply ditch the convenience store and focus on selling medicine — except CVS and Walgreens say it’s harder and harder to make a profit from this part of their business.
Years ago, a big shift in the power balance between pharmacies and health insurers revealed the limits of drugstores’ leverage.
“Historically, there was a view that there was a lot of customer loyalty to their specific retail pharmacy … and that patients, or consumers, would be all up in arms if they were forced to move their prescriptions,” says Brian Tanquilut, health care services analyst at the investment bank Jefferies.
Walgreens tested this theory about a decade ago when it got into a public fight with Express Scripts, a pharmacy benefit manager that worked with major health insurers.
Walgreens and Express Scripts played a game of chicken over how much Walgreens should earn from prescriptions — and Walgreens lost. For a time, it got kicked out of insurance networks used by millions of people, who simply went elsewhere to get their medicine at the lower in-network prices.
“What that did was to prove that patient loyalty is not to the retail pharmacy, but it actually is whatever my insurance is willing to pay,” Tanquilut says. “And that opened the door for the payers to keep pushing pricing down on retail pharmacy chains.”
Hoping reinvention is the cure
These days, CVS and Walgreens are facing tough competition from pharmacies that don’t depend as much on profits from prescriptions because they’re part of retail giants, including Walmart and Costco. The drugstore chains also have spent millions of dollars on government fines over allegations of unsafe staffing levels, overbilling government insurance programs and contributing to the opioid epidemic.
Over the years, CVS and Walgreens attempted to reframe themselves as health care hubs, expanding primary-care clinics. But these operations cost time and money.
On Tuesday, Walgreens CEO Wentworth said his chain is “reorienting to its legacy strength as a retail pharmacy-led company.” CVS is reportedly weighing a breakup to undo its mergers with Aetna and Caremark.
Both companies are also proposing new structures for how they want to be paid for filling prescriptions, hoping this is the big shot in the arm they need.
"I'm very confident that over a two- to three-year period we will have reset the framework for reimbursement discussions," Wentworth told investors on Tuesday. “We are in the early stages of a turnaround that will take time.”
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.












